Page 5 - Adverse Effect News Today

Cases of myocarditis – an inflammation of the heart muscle – following a third dose of the Pfizer vaccine are rare and typically mild, research from Israel shows.

A new study from Israel found that the risk of developing myocarditis among males ages 16 to 19 years was about 1 in 15,000 after third dose of the Pfizer-BioNTech COVID-19 vaccine, and the cases were rare and mild, according to new research published today in the American Heart Association's flagship journal Circulation.

The risk of developing myocarditis among males ages 16 to 19 years are about one in 15,000 after the third dose of the Pfizer-BioNTech Covid-19 vaccine, however the cases are rare and mild, according to a new research conducted in ...

Before the Covid pandemic, it was estimated that approximately 10 to 20 people per 100,000 were diagnosed with myocarditis each year, according to the American Heart Association (AHA).

The risk of developing myocarditis – an inflammation of the heart muscle – following...

FOR IMMEDIATE RELEASE -NEW YORK, NY., August 22, 2022 Hospira, Inc., a Pfizer company, is voluntarily recalling one lot of Propofol Injectable Emulsion (containing benzyl alcohol), 100mL Single Patient Use Glass Fliptop Vial; lot EA7470, to the user level due to visible particulates observed in two vials during annual examination of retention sampl

Elon Musk has recently received a lawsuit against him from Twitter, wherein the social media company accused him of breaching an agreement to procure the platform for $44 billion.

Grab the popcorn - the Twitter Musk feud just got even more interesting.

Elon Musk may have walked away from his Twitter purchase, but the story is far from over.

Market Trends: What You Need to Know - Over the past 15+ years covered by the ABA studies, materiality scrapes have morphed from being a somewhat uncommon provision, seen...